Today: 11 June 2026
Oil prices rise on U.S.-Iran flare-up; Brent nears $68 ahead of U.S. stockpile data
4 February 2026
2 mins read

Oil prices rise on U.S.-Iran flare-up; Brent nears $68 ahead of U.S. stockpile data

London, Feb 4, 2026, 11:38 GMT — Regular session

  • Brent crude rose 46 cents, or 0.7%, to $67.79 a barrel; WTI gained 52 cents, or 0.8%, to $63.73 by 1034 GMT
  • Traders rebuilt a “risk premium” as fresh U.S.-Iran incidents revived worries over Gulf shipping routes
  • Focus turns to U.S. inventory data later on Wednesday and U.S.-Iran talks in Oman on Friday

Oil prices edged higher on Wednesday after the U.S. shot down an Iranian drone and Iranian boats moved toward a U.S.-flagged vessel, pushing traders to price in fresh supply risk. Brent crude was up 46 cents, or 0.7%, at $67.79 a barrel by 1034 GMT, while U.S. West Texas Intermediate (WTI) was up 52 cents, or 0.8%, at $63.73.

The move matters because it puts the Strait of Hormuz back in play. A chunk of the world’s seaborne crude flows through that narrow waterway, and the market tends to react fast when the risk of disruption rises.

It also comes at an awkward moment for positioning. Traders have been trying to work out whether the week’s swings are a one-off geopolitical jolt or the start of something stickier, with supply risk meeting a shaky broader market tone.

Earlier in the week, crude had gone the other way. Oil settled more than 4% lower on Monday as signs of de-escalation in U.S.-Iran tensions weighed, while the stronger dollar and a broader commodities retreat added pressure, Reuters reported.

On Tuesday, prices snapped back. Brent rose $1.03, or 1.6%, to settle at $67.33 a barrel and WTI gained $1.07, or 1.7%, to settle at $63.21, after the latest incidents raised worries that diplomacy could be knocked off course. Bob Yawger, director of energy futures at Mizuho, wrote that the “diplomatic effort” to avoid a U.S. strike in Iran was “unravelling”. Reuters

The U.S. military said an Iranian Shahed-139 drone was flying toward the USS Abraham Lincoln aircraft carrier “with unclear intent” and was shot down by an F-35 jet in what it described as self-defence. Iran’s U.N. mission declined to comment, Reuters reported. Reuters

Separately, three pairs of Iranian gunboats approached the U.S.-flagged tanker Stena Imperative in the Strait of Hormuz north of Oman, maritime sources and a security consultancy said. Maritime risk management group Vanguard said the tanker did not enter Iranian internal waters and was escorted by a U.S. warship.

Oil has also found support from U.S. supply signals. Industry data cited by sources said U.S. crude stockpiles fell by more than 11 million barrels last week, based on figures from the American Petroleum Institute, an industry group; traders were waiting for the official U.S. government report.

That official report from the Energy Information Administration (EIA) — the U.S. government’s energy statistics agency — is due at 1530 GMT. Analysts polled by Reuters had expected a rise in crude inventories, which would cut against the bullish read from the API figures.

Diplomacy stays in the frame. The U.S. and Iran are due to hold talks in Oman on Friday after Tehran requested a venue change and pushed to keep the agenda focused on its nuclear programme, a regional official said; a source familiar with the situation said Jared Kushner and U.S. envoy Steve Witkoff were expected to take part, alongside Iranian Foreign Minister Abbas Araqchi.

Oil’s gains were capped by a broader equities selloff that has spilled into other risk-sensitive assets. Crude often tracks stocks on days when investors are de-risking, even when the oil-specific story points the other way.

The risk to the upside is obvious: any further incident that hints at disrupted shipping through Hormuz can add to the price. The risk the other way is just as clear — if the Oman talks look credible and the waterway stays quiet, the “risk premium” (the extra price traders pay for potential disruption) can drain out quickly, as Monday showed.

Stock Market Today

  • TIG Advisors Reduces Stake in Beazley PLC by 330,000 Shares
    June 11, 2026, 10:47 AM EDT. TIG Advisors, LLC, acting as discretionary investment manager for AlTi Global, Inc., disclosed a reduction in its long position in Beazley PLC's shares. After the deal on June 10, 2026, it held 5,928,546 derivative shares, representing 0.99% of Beazley's total securities (ISIN: GB00BYQ0JC66). The transaction involved selling 330,000 5p ordinary shares at a price of 1,283.00 pence per unit. The disclosure was made under Rule 8.3 of the UK's Takeover Code, which requires revealing interests exceeding 1% in relevant securities. This transaction signals a strategic portfolio adjustment by TIG Advisors in the insurance firm's equity.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Previous Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus
Next Story

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus

Go toTop